Invention Grant
- Patent Title: Peptides for treatment of scleroderma
- Patent Title (中): 用于治疗硬皮病的肽
-
Application No.: US11830687Application Date: 2007-07-30
-
Publication No.: US07994132B2Publication Date: 2011-08-09
- Inventor: Alan M. Fogelman , Gattadahalli M. Anantharamaiah , Mohamad Navab
- Applicant: Alan M. Fogelman , Gattadahalli M. Anantharamaiah , Mohamad Navab
- Applicant Address: US CA Oakland US AL Birmingham
- Assignee: The Regents of the University of California,The UAB Research Foundation
- Current Assignee: The Regents of the University of California,The UAB Research Foundation
- Current Assignee Address: US CA Oakland US AL Birmingham
- Agency: Weaver Austin Villeneuve & Sampson LLP
- Agent Tom Hunter
- Main IPC: A61K38/10
- IPC: A61K38/10
Abstract:
Peptides are provided that ameliorate one or more symptoms of scleroderma. In various embodiments, the peptides range in length from about 10 to about 30 amino acids, comprise a class A amphipathic helix, and bear at least one protecting group. The peptides are highly stable and readily administered via an oral route.
Public/Granted literature
- US20080096816A1 ORALLY ADMINISTERED PEPTIDES SYNERGIZE STATIN ACTIVITY Public/Granted day:2008-04-24
Information query
IPC分类:
